Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Melanoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a vaccine therapy for metastatic melanoma is described. The trial is sponsored by Baylor Health Care System.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: Baylor Health Care System | Conditions: Melanoma (Skin) | Phase 1 | Status: UNKNOWN